Mucormycosis in patients with inflammatory bowel disease: Case series and review of the literature

Maheen Z. Abidi, Nayantara Coelho-Prabhu, James Hargreaves, Tim Weiland, Irminne Van Dyken, Aaron Tande, Pritish K. Tosh, Randall C. Walker, Nathan W. Cummins

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations

Abstract

Mucormycosis is a rare and often fatal invasive fungal infection mostly seen in immune-compromised individuals. A high index of clinical suspicion is necessary, so that effective preemptive therapy can be started, as timely intervention is crucial. In this series we present three cases of invasive mucormycosis in patients with underlying inflammatory bowel disease that had received therapy with immunomodulators prior to the infection. All three had varied clinical manifestations. We also review the literature of invasive mucormycosis in patients with inflammatory bowel disease.

Original languageEnglish (US)
Article number637492
JournalCase Reports in Medicine
Volume2014
DOIs
StatePublished - 2014

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Mucormycosis in patients with inflammatory bowel disease: Case series and review of the literature'. Together they form a unique fingerprint.

Cite this